Follicular lymphoma: Update on management and emerging therapies at the dawn of the new decade
Sign Up to like & getrecommendations! Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.2711
Abstract: Follicular lymphoma is the most common indolent non‐Hodgkin lymphoma. Survival has improved over the last several decades, mainly because of the incorporation of the anti‐CD20 antibody rituximab into preexisting or rediscovered agents. The disease has… read more here.
Keywords: lymphoma; treatment; follicular lymphoma; biology ... See more keywords
[Follicular lymphoma: An update].
Sign Up to like & getrecommendations! Published in 2019 at "Presse medicale"
DOI: 10.1016/j.lpm.2019.07.024
Abstract: Follicular lymphoma, the second most common lymphoma, is characterized by its slow growth and is often considered incurable in advanced stages. Progresses in biology have contributed to better understand the complex and successive mechanisms of… read more here.
Keywords: lymphoma; follicular lymphoma; pathology; biology ... See more keywords
Plasmablastic lymphoma: An update
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Laboratory Hematology"
DOI: 10.1111/ijlh.13863
Abstract: Plasmablastic lymphoma (PBL) is a highly aggressive B cell non‐Hodgkin lymphoma frequently associated with immunosuppression, particularly human immunodeficiency virus (HIV) infection. Although PBL is rare globally, South Africa has a high burden of HIV infection… read more here.
Keywords: laboratory; plasmablastic lymphoma; cell; lymphoma ... See more keywords